 | Study programme 2025-2026 | Français | |
 | Développement pharmaceutique et industriel + visites industries | ||
Programme component of Master's in Pharmacy (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M2-PHARMA-025-M | Optional UE | VANDERBIST Francis | M111 - Pharmacie Galénique et Biopharmacie |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Français | 12 | 0 | 0 | 0 | 0 | 1 | 1.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-DOYM-228 | Notions de développement industriel pharmaceutique incluant des visites d'industries | 12 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
Année académique 2023-2024
Notions of industrial pharmaceutical development pharmaceutical (including visits of pharmaceutical industries).
The objective of this lesson is to familiarize the students with pharmaceutical manufacturing and analysis of a drug at the industrial stage.
In particular, the notions of Good Manufacturing Practices (GMP) will be teached together with main quality tools required.
Furthermore, one of two visits of pharmaceutical companies will be organized to allow students to discover the industrial manufacturing in GMP conditions.
UE Content: description and pedagogical relevance
Année académique 2023-2024
Conten of l'UE (10h):
Notions of industrial pharmaceutical a pharmaceutical development(including visits of pharmaceutical industries).
The objective of this lesson is to familiarize the students with pharmaceutical manufacturing and analysis of a drug at the industrial stage.
In particular, the notions of Good Manufacturing Practices (GMP) will be teached together with main quality tools required.
Furthermore, one or several visits of pharmaceutical companies will be organized to allow students to discover the industrial manufacturing in GMP conditions.
Prior Experience
Good knowledge of galenics and pharmaceutical Technology
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-DOYM-228 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-DOYM-228 |
|
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-DOYM-228 | Good Manufacturing Practices (GMP) |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-DOYM-228 | None |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-DOYM-228 | None |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-DOYM-228 | Authorized |
Term 1 Assessment - type
| AA | Type(s) and mode(s) of Q1 assessment |
|---|---|
| M-DOYM-228 |
|
Term 1 Assessment - comments
| AA | Term 1 Assessment - comments |
|---|---|
| M-DOYM-228 | The assessment of the student's knowledge will occur through short a questionnaire about the main information gained during the visit visits to the pharmaceutical industry. |
Resit Assessment - Term 1 (BAB1) - type
| AA | Type(s) and mode(s) of Q1 resit assessment (BAB1) |
|---|---|
| M-DOYM-228 |
|
Resit Assessment - Term 1 (BAB1) - Comments
| AA | Resit Assessment - Term 1 (BAB1) - Comments |
|---|---|
| M-DOYM-228 | not applicable |
Term 3 Assessment - type
| AA | Type(s) and mode(s) of Q3 assessment |
|---|---|
| M-DOYM-228 |
|
Term 3 Assessment - comments
| AA | Term 3 Assessment - comments |
|---|---|
| M-DOYM-228 | Idem Q1 |